Table 4

Changes in GSRS scores by FLV and FLV+TJ-43 treatment.
GSRS score
 pre-treatment
 post-treatment
Total


     FLV
 2.42 ± 1.24
 2.52 ± 0.99
 n.s.
     FLV+TJ-43
 2.45 ± 1.10
 1.97 ± 0.81
 *
Reflux


     FLV
 2.13 ± 1.46
 2.50 ± 1.35
 n.s.
     FLV+TJ-43
 2.37 ± 1.61
 2.00 ± 0.91
 n.s.
Abdominal pain


     FLV
 2.63 ± 1.56
 3.18 ± 1.81
 n.s.
     FLV+TJ-43
 3.03 ± 1.82
 2.18 ± 1.00
 +
Indigestion


     FLV
 1.70 ± 0.97
 1.87 ± 0.74
 n.s.
     FLV+TJ-43
 2.05 ± 0.95
 1.78 ± 1.06
 n.s.
Diarrhea


     FLV
 2.87 ± 1.78
 2.35 ± 1.60
 n.s.
     FLV+TJ-43
 2.25 ± 1.47
 1.65 ± 1.06
 +
Constipation


     FLV
 2.64 ± 1.87
 2.83 ± 1.33
 n.s.
     FLV+TJ-43
 2.66 ± 1.69
 2.34 ± 1.53
 n.s.

FLV = fluvoxamine; TJ-43 = Rikkunshito. mean ± SD. * p < 0.05, + p < 0.1 by paired t-test.

Oka et al. BioPsychoSocial Medicine 2007 1:21   doi:10.1186/1751-0759-1-21
Open Data